In our study, the long lag time (almost 15 years) between sample donation and glioblastoma diagnosis indicates that increased serum EGFR and ErbB2 are likely to be associated with an etiological factor more than with the effects of undiagnosed disease (i.e., reverse causation). This evidence concerns the gene EGFR and glioblastoma.